ARCHIVES

DeVita Defends CHP Awards, Says Program Has High Priority

This article is from The Cancer Letter archive.

Vol. 06 No. 35 | September 5, 1980

Download PDF Visit The Full Archive

Related Articles

Survivorship Studies Unfocused As Total Research Increases

November 25, 2011

In Brief: John Minton Dies Forom Auto Accident Injuries; FDA Rules Against Generic Megastrol Acetate

January 11, 1991

Advisors Reaffirm Survival As Standard For full FDA Approval Of Cancer Drugs

June 16, 1999

NCI Director Broder’s Year In Review: Avoid Politics, Stay Focused On Science

October 28, 1994

2,000 Breast Cancer Recurrence Biomarker Candidates Discovered

August 31, 2012

Duke Officials Decline To Provide Details Of Probe

July 23, 2010